Improving Outcomes in Corneal Endothelial Disease With Cell TherapyByGreg KunstJanuary 20th 2022Greg Kunst, chief executive officer, Aurion Biotech, discussed the potential of cell therapy in treating people with corneal endothelial disease around the world.